Kimera–Test® is the first genetic test capable of HPV genotyping and detection of genetic susceptibility to cervical and prostate cancer simultaneously.


Urine Test non-invasive.

Detection and genotyping of 15 types of high-risk HPV (Human Papilloma Virus).

Identification of polymorphisms for cervical cancer risk.

Identification of  polymorphisms for prostate cancer risk.

Results from1 to 5 days.

High Precision and Sensibility

Clear results that allow the doctor and the patient to choose a personalized monitoring plan and selection of treatment.

Recomended for men and women with a sexually active life.

Genetic tests are a fundamental tool in the area of ​​Genetic Counseling. The information generated through these tools helps personalized medicine to prevent and treat diseases such as cancer.

Kimera will be available

Request more information